LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Replicate Assay Well Timepoint Timepoint Unit Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Relative Growth Rate After Treatment
SK-BR-3 CP466722
0.37
uM
LJP5
 3
I10
 72
hr
 1401 4525 4223 1.0715 1.1070
SK-BR-3 Crizotinib
0.37
uM
LJP5
 1
A22
 72
hr
 1401 3634 4223 0.8605 0.7912
SK-BR-3 Crizotinib
0.37
uM
LJP5
 2
A22
 72
hr
 1401 4153 4223 0.9834 0.9752
SK-BR-3 Crizotinib
0.37
uM
LJP5
 3
A22
 72
hr
 1401 4075 4223 0.9649 0.9475
SK-BR-3 Momelotinib
0.37
uM
LJP5
 1
P10
 72
hr
 1401 3786 4223 0.8965 0.8451
SK-BR-3 Momelotinib
0.37
uM
LJP5
 2
P10
 72
hr
 1401 3904 4223 0.9244 0.8869
SK-BR-3 Momelotinib
0.37
uM
LJP5
 3
P10
 72
hr
 1401 4150 4223 0.9827 0.9741
SK-BR-3 Dasatinib
0.37
uM
LJP5
 1
D04
 72
hr
 1401 3952 4223 0.9358 0.9039
SK-BR-3 Dasatinib
0.37
uM
LJP5
 2
D04
 72
hr
 1401 4491 4223 1.0634 1.0950
SK-BR-3 Dasatinib
0.37
uM
LJP5
 3
D04
 72
hr
 1401 4480 4223 1.0608 1.0911
SK-BR-3 Dasatinib
0.37
uM
LJP6
 1
I04
 72
hr
 1401 3983 4223 0.9432 0.9149
SK-BR-3 Dasatinib
0.37
uM
LJP6
 2
I04
 72
hr
 1401 4336 4223 1.0267 1.0400
SK-BR-3 Dasatinib
0.37
uM
LJP6
 3
I04
 72
hr
 1401 3194 4223 0.7563 0.6353
SK-BR-3 Dovitinib
0.37
uM
LJP5
 1
E22
 72
hr
 1401 2391 4223 0.5662 0.3507
SK-BR-3 Dovitinib
0.37
uM
LJP5
 2
E22
 72
hr
 1401 2408 4223 0.5702 0.3567
SK-BR-3 Dovitinib
0.37
uM
LJP5
 3
E22
 72
hr
 1401 2801 4223 0.6633 0.4960
SK-BR-3 Enzastaurin
0.37
uM
LJP5
 1
D16
 72
hr
 1401 4413 4223 1.0450 1.0673
SK-BR-3 Enzastaurin
0.37
uM
LJP5
 2
D16
 72
hr
 1401 5062 4223 1.1986 1.2973
SK-BR-3 Enzastaurin
0.37
uM
LJP5
 3
D16
 72
hr
 1401 4331 4223 1.0256 1.0382
SK-BR-3 Erlotinib
0.37
uM
LJP5
 1
M22
 72
hr
 1401 3776 4223 0.8941 0.8416
SK-BR-3 Erlotinib
0.37
uM
LJP5
 2
M22
 72
hr
 1401 4096 4223 0.9699 0.9550
SK-BR-3 Erlotinib
0.37
uM
LJP5
 3
M22
 72
hr
 1401 4292 4223 1.0163 1.0244
SK-BR-3 Foretinib
0.37
uM
LJP5
 1
H10
 72
hr
 1401 1674 4223 0.3964 0.0966
SK-BR-3 Foretinib
0.37
uM
LJP5
 2
H10
 72
hr
 1401 1664 4223 0.3940 0.0930
SK-BR-3 Foretinib
0.37
uM
LJP5
 3
H10
 72
hr
 1401 1983 4223 0.4696 0.2061